| [1] |
1 Yue FY, Dummer R, Geertsen R, et al. Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class- Ⅰ, HLA class- Ⅱ and ICAM- 1 molecules [J]. Int J Cancer, 1997, 71(4): 630~ 637
2 Boyano MD, Garcia-Vazquez MD, Lopez Michelena T, et al. Soluble interleukin- 2 receptor, intercellular adhesion molecule- 1 and interleukin- 10 serum levels inpatients with melanoma[J]. Br J Cancer, 2000, 83(7): 847~ 852
3 Galizia G, Lieto E, De Vita, et al. Circulating levels of interleukin- 10 and interleukin- 6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome [J]. J Interferon Cytokine Res, 2002, 22(4): 473~ 482
4 Sharma S, Stolina M, Lin Y, et al. T-cell derived IL-10 promotes lung cancer growth by suppressing both T-cell and APC function[J]. J Immunol, 1999, 163(9): 5020~ 5028
5 Knolle PA, Uhrig A, Hegenbarth S. IL- 10 down-regulates T-cell activation by anti- presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules [J]. Clin Exp Immunol, 1998, 114(3): 427~ 433
6 Groux H, Bigler M, De Vries. Inhibitory and stimulatory effects of IL- 10 on human CD8+ T cell [J]. J Immunol, 1998, 160(7): 3188~ 3193
7 Steinbrink K, Jonuleit H, Muller G, et al. Interleukin-10 treated human dendritic cells induce a melanoma antigen specific anergy in CD8+ T cell resulting in a failure to lyse tumor cells[J]. Blood, 1999, 93(5): 1634~ 1642
8 Elnemr A, Ohta T, Yachie A, et al. Human pancreatic cancer cells express non- functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape[J]. Int J Oncol , 2001, 18(1): 33~ 39
9 齐法莲,徐 军,杜秀敏,等.肺部良恶性疾病手术前后血清 IL- 10测定的临床意义[J].放射免疫学杂志,2003,16(4):198~ 200
10 刘振玉,方向明,路作新,等.IL- 10 在肺癌细胞中表达的意义及其影响因素的探讨[J].实用癌症杂志,2000,15(5):489~ 491
11 金 涌,朱金水,陈维雄,等. 腹腔免疫化学对晚期结肠癌癌性腹水患者 IL- 6 及 IL- 10 影响[J].中国临床医学,2002,9(5):519~ 520
|
下载:
